Tonix Pharmaceuticals Reports Topline Results from Phase 3 RECOVERY Study of TNX-102 SL in PTSD and Outlines Future Development Plans

    NEXT STORY
    uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program
    PREV STORY
    Outlook on the Biopreservation Global Market to 2026 – Profiling Avantor, BioLife Solutions and ThermoGenesis Among Others
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aduro Biotech to Present at ROTH Conference

    BERKELEY, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Presentations on Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences

    COPENHAGEN, Denmark, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Botulinum Toxin Market revenue to cross USD 8.9 Bn by 2026: Global Market Insights, Inc.

    author_avatar
    NASDAQ Market News